GlassScriptPhysician profile
Marjorie Chano
NPI 1295111912
$4,255.32
in general payments reported to CMS, 2019-2025
20 companies · $1,360 in 2025
The $1,360 reported for 2025 was more than what 85% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $385 · 2022: $438 · 2023: $1,205 · 2024: $867 · 2025: $1,360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,357 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,356.96 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $757.63 | 2021-2025 | Jemperli, Zejula |
| Merck Sharp & Dohme LLC | $756.68 | 2021-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Myriad Genetic Laboratories, INC. | $607.99 | 2022-2025 | Myrisk, Precisetumor |
| Seagen INC. | $428.46 | 2021-2023 | Tivdak |
| Abbvie INC. | $420.32 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $263.72 | 2023-2025 | Lynparza |
| Eisai INC. | $243.67 | 2021-2024 | |
| Astellas Pharma US INC | $231.45 | 2023-2025 | Veozah |
| Pfizer INC. | $127.00 | 2024-2025 | |
| Caris Mpi, INC. | $84.99 | 2025 | Mi Cancer Seek |
| Hologic Sales and Service, LLC | $64.76 | 2021-2024 | Acessa Provu System |
| Clovis Oncology, INC. | $51.25 | 2021-2022 | |
| Verastem, INC. | $48.06 | 2025 | Avmapki Fakzynja Co-Pack |
| Sumitomo Pharma America, INC. | $36.09 | 2023-2025 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $32.87 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $27.77 | 2025 | Enhertu |
| Olympus America INC. | $23.61 | 2023 | Olympus |
| Innovation Technologies INC | $17.96 | 2025 | Irrisept |
| Exeltis, USA INC. | $15.93 | 2025 | Slynd |
| Coopersurgical, INC. | $15.11 | 2025 | Ally II Ups |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marjorie Chano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.